Consonance Capital

Consonance Capital Management as of March 31, 2020

Portfolio Holdings for Consonance Capital Management

Consonance Capital Management holds 31 positions in its portfolio as reported in the March 2020 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Karyopharm Therapeutics (KPTI) 10.3 $138M 7.2M 19.21
United Therapeutics Corporation (UTHR) 9.5 $128M 1.4M 94.83
Aurinia Pharmaceuticals (AUPH) 7.5 $100M 6.9M 14.51
Chemocentryx 6.9 $92M 2.3M 40.18
Sarepta Therapeutics (SRPT) 6.0 $81M 823k 97.82
Kadmon Hldgs 4.9 $65M 16M 4.19
Omeros Corporation (OMER) 4.5 $60M 4.5M 13.37
Caredx (CDNA) 4.3 $58M 2.7M 21.83
Akebia Therapeutics (AKBA) 4.0 $54M 7.1M 7.58
Epizyme 3.8 $51M 3.3M 15.51
Uniqure Nv (QURE) 3.6 $49M 1.0M 47.45
Assembly Biosciences 3.5 $47M 3.2M 14.83
Principia Biopharma 3.0 $41M 690k 59.38
Cytokinetics (CYTK) 3.0 $41M 3.4M 11.79
Axogen (AXGN) 2.8 $37M 3.6M 10.40
Kiniksa Pharmaceuticals 2.6 $35M 2.2M 15.48
Aptose Biosciences 2.6 $34M 5.8M 5.94
Retrophin 2.5 $34M 2.3M 14.59
Coherus Biosciences (CHRS) 2.4 $33M 2.0M 16.22
Krystal Biotech (KRYS) 2.1 $28M 655k 43.24
Intra Cellular Therapies (ITCI) 1.9 $25M 1.7M 15.37
Xenon Pharmaceuticals (XENE) 1.7 $22M 2.0M 11.34
Liminal Biosciences 1.6 $22M 3.3M 6.69
Bellus Health 1.2 $16M 1.6M 9.98
Oxford Immunotec Global 0.9 $12M 1.2M 9.26
Iveric Bio 0.8 $11M 3.2M 3.44
Adma Biologics (ADMA) 0.7 $9.7M 3.4M 2.88
Axovant Gene The 0.7 $8.9M 3.7M 2.44
Ovid Therapeutics (OVID) 0.6 $7.7M 2.6M 2.98
Biotelemetry 0.1 $1.9M 49k 38.50
Apellis Pharmaceuticals (APLS) 0.0 $268k 10k 26.80